Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 26 December 2022 Vol. No. 11; Issue No. 558

1. Singh B, Patnaik C, Bahadur R, Gandhi M, De A, Srivastava R (2022). Synthesis and degradation mechanism of renally excretable gold core-shell nanoparticles for combined photothermal and photodynamic therapy. Nanoscale.

2. Acharekar A, Bachal K, Shirke P, Thorat R, Banerjee A, Gardi N, Majumder A, Dutt S (2022). Substrate stiffness regulates the recurrent glioblastoma cell morphology and aggressiveness. Matrix Biology.

3. Singh C, Yanamandra U, Karunakaran P, Jindal N, Kumar SR, Saini N, Jandial A, Jain A, Das C, Lad D, Prakash G, Khadwal A, Naseem S, Das R, Varma N, Varma S, Malhotra P (2022). Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre study. British Journal of Haematology.

Site of the Week

AlphaFold DB provides open access to over 200 million protein structure predictions to accelerate scientific research.

desktop Image
Interesting Reads

Allen GM, Frankel NW, Reddy NR, Bhargava HK, Yoshida MA, Stark SR, Purl M, Lee J, Yee JL, Yu W, Li AW, Garcia KC, El-Samad H, Roybal KT, Spitzer MH, Lim WA. Synthetic cytokine circuits that drive T cells into immune-excluded tumors. Science. 378(6625):eaba1624.

Legends of Science
Krishna Kumar Nanda Krishna Kumar Nanda

Krishna Kumar Nanda obtained his PhD from the University of Mumbai in 1947. He specialized in plant physiology and biochemistry. By studying the endogenous rhythms, the effect of light and temperature on reproductive development and the growth pattern of plant yield, he developed the crop-weather models for enhancing the yield. He also worked on the problems of floral bud initiation on woody plants. He received the Rafi Ahmed Kidwai Memorial Award, Birbal Sahni Medal and SM Sircar Memorial Medal. He was the President Indian Botanical Society, a Member of the Japanese Society for Plant Physiology, the Indian Society of tree Scientists and the American Association for Advancement of Science.

Chirayathumadom Venkatachalier Subramanian Chirayathumadom Venkatachalier Subramanian

C V Subramanian, a Mycologist, taxonomist and plant pathologist, obtained his PhD from the University of Madras in 1948. His significant research was on the classification of Fungi Imperfecti. Mycobank, an online repository, listed 384 genera of fungi he named. He assisted in reclassifying the genus Dematiaceous hyphomycetes. He received the S S Bhatnagar award in 1965. He is an elected Fellow of the Indian Academy of Sciences and the Indian National Science Academy. Dr Subramanian is an honorary member of the Mycological Society of America.

Upcoming Events
42nd Annual Conference of the Indian Association for Cancer Research

12-16 January, 2023

At Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai.

Quantitative Hallmarks of the Tumor Microenvironment

04-05 February, 2023

At Grand Galvez, Galveston, TX, United States.

18th St. Gallen International Breast Cancer Conference 2023

15-18 March, 2023

At Austria Center Vienna, Austria.

Do You Know?

In 1934, W Burton Wood and S R Gloyne reported the first two cases of lung cancer linked to asbestos.

back Image
Cancer News
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced HCC patients

22 December 2022, MedicalXpress

The study included unresectable HCC patients scheduled to receive Atezo/Bev. Patients were followed to determine progression-free survival (PFS) and overall survival (OS)...

First test of anti-cancer agent PAC-1 in human clinical trials shows promise

22 December 2022, EurekAlert

A phase I clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with end-stage cancers...

IISc researchers find new way to treat advanced brain cancer

24 December 2022, Deccan Herald

A recent IISc research has identified a molecule generated by brain cancer cells, which could be targeted to cure Glioblastoma, an advanced type of cancer. The finding has implications in developing new drugs to better treat the cancer arising from the brain’s glial cells…

2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)